Q&A: Roche's Dan Chen Talks Immuno-Oncology Combinations
This article was originally published in The Pink Sheet Daily
Executive Summary
The head of Roche/Genentech's immuno-oncology programs sat down with the Pink Sheet at the recent American Society of Clinical Oncology annual meeting in Chicago.